A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis

Journal of Cosmetic Dermatology

Volumn 9, Issue 1, 2010, Pages 16-21

  Bissonnette, Robert ^a   Maari, Catherine ^a   Provost, Nathalie ^a   Bolduc, Chantal ^a   Nigen, Simon ^a   Rougier, André ^b   Seite, Sophie ^b  

^a INNOVADERM RESEARCH   (Canada)

^b La Roche Posay Pharmaceutical Laboratories   (France)

Author keywords

Atopic dermatitis; Efficacy; Moisturizer; Safety

Indexed keywords

DERMATOLOGICAL AGENT; ISO UREA; UNCLASSIFIED DRUG; UREA; UREA MOISTURIZER;

ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; ENTERITIS; ERYTHEMA; FEMALE; HUMAN; IRRITANT DERMATITIS; LOTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING ATOPIC DERMATITIS SEVERITY INDEX; SCORING SYSTEM; SKIN PRURITUS; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; ALGORITHMS; CANADA; DERMATITIS, ATOPIC; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; EMOLLIENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UREA;

EID: 77954351676     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2010.00476.x     Document Type: Article

References (9)

1. Mohrenschlager M, Ring J. Atopic eczema. Curr Allergy Asthma Rep 2006, 6:445-7.
2. Wise RD. A review of atopic dermatitis. Compr Ther 2006, 32:111-7.
3. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, Luger TA, Muraro A, Novak N, Platts-Mills TA, Rosenwasser L, Scheynius A, Simons FE, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006, 61:969-87.
4. Spergel JM, Leung DY. Safety of topical calcineurin inhibitors in atopic dermatitis: evaluation of the evidence. Curr Allergy Asthma Rep 2006, 6:270-4.
5. Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003, 4:771-88.
6. Loden M, Andersson AC, Anderson C, Bergbrant IM, Frodin T, Ohman H, Sandstrom MH, Sarnhult T, Voog E, Stenberg B, Pawlik E, Preisler-Haggqvist A, Svensson A, Lindberg M. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol 2002, 82:45-7.
7. Loden M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999, 140:264-7.
8. Rudolph R, Kownatzki E. Corneometric, sebumetric and TEWL measurements following the cleaning of atopic skin with a urea emulsion versus a detergent cleanser. Contact Dermatitis 2004, 50:354-8.
9. Kunz B, Oranje AP, Labreze L, Stalder JF, Ring J, Taib A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 1997, 195:10-9.